News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioXell S.p.A. And ProSkelia S.A.S Announce R&D Collaboration



10/19/2005 5:09:39 PM

BioXell SpA and ProSkelia SAS today announced the signing of a collaborative agreement to research and develop drug candidates based on Vitamin D3 analogues for the treatment of osteoporosis and secondary hyperparathyroidism (HPT).



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES